Explore the fascinating journey of platinum-based anticancer drugs from accidental discovery to revolutionary cancer treatment and future innovations.
Explore how lomeguatrib is revolutionizing cancer treatment by overcoming chemotherapy resistance through MGMT inhibition.
Discover how bortezomib sensitizes glioblastoma with unmethylated MGMT promoter to temozolomide-chemotherapy through MGMT depletion and abrogated autophagy flux
Exploring innovative strategies to prevent and treat anthracycline-induced cardiotoxicity while preserving cancer treatment efficacy
Discover how scientists are creating smart cancer drugs that target tumors with precision and release chemotherapy only inside cancer cells, reducing side effects.
Understanding anthracycline extravasation - a serious complication of cancer treatment where chemotherapy drugs leak into surrounding tissues, causing severe damage.
Explore how Cathepsin B-cleavable cyclopeptidic prodrugs act as molecular Trojan horses to deliver chemotherapy precisely to cancer cells, reducing side effects.
Discover how glycan-based paclitaxel prodrugs target cancer cells through glucose transporters for more precise chemotherapy with fewer side effects.
Exploring how ruthenium complexes are emerging as promising alternatives to platinum-based cancer therapies with improved targeting and reduced side effects.
Exploring how metal-containing macromolecules are revolutionizing cancer treatment with targeted therapy and reduced side effects.